Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 8/30/2022
Blood
Date: 11 2008
www.bloodjournal.org
High-Dose Cytarabine-Mitoxantrone Versus Hyper-CVAD in Adult Acute Lymphoblastic Leukemia and Burkitt’s Lymphoma: A Single Center Experience of Two Induction Regimens
The Open Leukemia Journal
Volume: 2
Date: 01 2009
www.bentham.org/open/toleukemiaj/index.htm
Temozolomide and Cisplatin in relapsed/ refractory Acute Leukemia
Journal of Hematology & Oncology
Volume: 2:21
Date: 05 2009
www.Jhoonline.org
A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor risk stage III non-small cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)
Journal of Thoracic Oncology
Volume: 10
Date: 01 2015
Psychological predictors of chemotherapy-induced nausea in women with breast cancer: Expectancies and perceived susceptibility
European Journal Of Cancer Care
Date: 07 2021
https://onlinelibrary.wiley.com/doi/full/10.1111/ecc.13488
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
Journal of Clinical Oncology
Volume: 39
Date: 08 2021
https://ascopubs.org/doi/10.1200/JCO.21.00286?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_da
